Mark Mobius is famous as an emerging markets manager at Franklin Templeton, where he worked since 1987. (He retired this year... then unretired to start his own asset management firm.)
He's also famous for his distinctive shaved head and white suits. He looks like actor Yul Brynner.
Mobius was on the road at least 250 days a year during his career at Templeton – visiting rubber plantations in Thailand, oil wells in Nigeria, or mining camps in Peru. He's racked up all kinds of awards. He survived the investment game for more than 30 years – and he has
In a February interview with financial magazine Barron's, he opened up about a mistake he made – one that keeps many good investors from ever having a shot at a 100-bagger, much less a five-bagger.
I've spent years researching the best way to find 100-baggers. Today, I'll share how Mobius' mistake can help you in your search for these big winners...
Let's start with the interview. Mobius opined about many things and delivered a good line about bitcoin: "Whenever people ask me about bitcoin, I say I don't talk about religion in public."
But here's the key exchange I want to draw your attention to:
Barron's: What is a mistake you made that others can learn from?
Mobius: I was too rigid at times. We would focus too much on metrics like price/earnings and price/book ratios, and didn't pay enough attention to the total picture. We didn't have the imagination of what could happen over five or 10 years...
In my study of 100-baggers, I found that most were not obviously cheap at the time they began their runs.
Meanwhile, almost all of them required that their investors have a deep understanding of the business and a strong belief
A truly great business that can grow many times its current size is not often available at a low price-to-earnings (P/E) ratio. If investing were as simple as buying stocks when they have low P/E ratios, then a lot more people would be rich.
But it is hard to get rich in such a rote way. And most people get stuck on one of their favorite metrics. I've done it. Almost everybody has.
Even the best investors make this mistake...
François Rochon, who founded Giverny Capital (and is currently one of its money managers), shared a classic example. At a Google Talk this past December, he reminisced about the now-famous coffee chain Starbucks (SBUX):
I looked at it, I think the first time was in 1994. I thought that was a unique business... When I first tried Starbucks, I said, "Well, these people are on to something, and they'll do well." ... Howard Schultz was a very ambitious and a very driven CEO. He was very confident that Starbucks could have thousands and thousands and thousands of coffee stands everywhere in U.S. and in the world. I thought it was indeed possible...
But he didn't buy it. Why not?
The only thing that prevented me to invest 23 years ago was the P/E ratio of Starbucks. I remember it was trading at 40 times earnings. That was way too high for me... I didn't look lately, because it's too painful, but the stock is probably 100-fold since then.
In fact, SBUX shares are up more than 100-fold since 1994, adjusted for dividends.
We have all probably had similar experiences as investors.
Another example makes a similar point. E-commerce giant Amazon (AMZN) has crushed retailers of all kinds. From Sears (SHLD) to Barnes & Noble (BKS) to Bed Bath & Beyond (BBBY)... all their stock prices have collapsed as Amazon took away sales and profits.
Yet, shares of electronics retailer Best Buy (BBY) have outperformed Amazon shares since the beginning of 2013. See the chart below...
Five years ago, I think you would've found few people willing to make the bet that Best Buy would stand a chance against Amazon's onslaught.
Even the story of Amazon is a great dish of humble pie for many investors...
Back in 1998, I wouldn't have touched it. The Internet bubble was on, and Amazon looked like a seriously expensive bookseller. When the tech bubble collapsed in 2000-2002, Amazon lost more than 90% of its value.
And yet, Amazon has delivered a return of 32% annually since 1998. A $10,000 investment would be worth $2.7 million today – even with that 90% drop!
Prediction is hard. Cause and effect
My point here isn't to ignore valuation... That would be foolish. My point is not to rely on any single metric – of any sort.
This simple mistake has kept even great investors from making multiple times their money. To avoid it, remember to think more comprehensively about the business... And be humble about what you know.
Editor's note: Chris recently revealed an investment method he's spent three years and $138,545 developing... a blueprint he believes you can use to find stocks with 10-to-1 upside. He's so confident in this strategy, he's putting his reputation on the line to prove it. Click here to learn more.
While value isn't all that matters, Chris agrees that it plays a crucial role – for one thing, it's part of understanding the broader company. And right now, it can give you an edge as a stock picker... Learn more here: The Best Place to Find Value in Today's Overvalued Market.
"If investing were easy, everyone would be rich," Chris writes. In a recent essay, he shares more investing mistakes to avoid – and more advice for building a robust portfolio. Read more here: Four Steps to 'Bulletproof' Your Portfolio.
Today’s chart highlights a big shift in the
As regular readers know, our colleague David Eifrig is bullish on health care stocks. All Baby Boomers will be older than 65 by 2030, according to the U.S. Census Bureau. That means 1 in five citizens will be of retirement age. And they’ll likely be making more visits to the doctor…
That’s where Laboratory Corporation of America (LH) comes in. The $19 billion company, best known as LabCorp, is the world’s leading diagnostics firm. It operates its own network of medical laboratories, providing services like blood tests, urinalyses, and at-home testing kits. And it seems an influx of aging patients is already driving growth… LabCorp brought in more than $2.8 billion of revenue in the first quarter, an 18% year-over-year increase.
For shareholders, the upside of this trend speaks for itself. LabCorp’s stock has climbed nearly 50% over the past two years, recently hitting a new all-time high. As America’s elderly population grows,